Problems of Social Hygiene, Public Health and History of MedicineProblems of Social Hygiene, Public Health and History of Medicine0869-866X2412-2106Joint-Stock Company Chicot183510.32687/0869-866X-2023-31-3-368-378Научная статьяTHE PRESENT-DAY EPIDEMIOLOGY: CHALLENGES OF PUBLIC HEALTH AND POSSIBILITIES TO SETTLE THEM: THE PUBLICATIONS REVIEWKazakovS. D.KamenskikhE. M.SokolovaT. S.FedorovaО. S.The Federal State Budget Educational Institution of Higher Education “The Siberian State Medical University” of the Minzdrav of Russia, 634050, Tomsk, Russia2906202331336837803072025Copyright © 2023,2023Actually, the epidemiology is a dynamically developing medical science located at the intersection of social and biological branches of knowledge and bio-informatics. The new sources of data, the new methods create unique opportunities for epidemiologist. The number of epidemiological studies carrying out at the junction of several adjacent disciplines is increasing that requires harmonious interaction of specialists of different branches of medical knowledge. The change of the structure of global mortality towards chronic non-communicable diseases significantly affected the vector of epidemiological studies. Many interventional epidemiological projects are targeted to evaluation of effectiveness of new methods of prevention of cardiovascular, metabolic and oncological diseases. However, in recent years, the fight against unremembered infections affecting about 1 billion of people and taking away lives of 0.5 million people annually gained new importance. The current COVID-19 pandemic also affected epidemiology of communicable and chronic non-communicable diseases. Great attention is also currently attended to studying influence of social, economic and environmental factors on human health. The increase of average life expectancy of population contributes to development of epidemiology of the elderly. The new projects are initiated in the field of pharmacoepidemiology targeted to studying effectiveness of medications. The review of national and foreign publications considering current trends and achievements in the field of epidemiology. The reference retrieval engines such as PubMed, Google Scholar, CyberLeninka were used. The current directions of epidemiological research are analyzed. The challenges and development prospects of development of modern epidemiology are highlighted.epidemiologyepidemiological studieschronic non-communicable diseasesinfectious diseasesbio-informaticspublications review.эпидемиологияэпидемиологические исследованияхронические неинфекционные заболеванияинфекционные заболеваниябиоинформатикаобзор литературы.[Ротарь О. П. Эпидемиология: вчера, сегодня, завтра (краткий экскурс в историю эпидемиологии и обзор наиболее актуальных проблем). Артериальная гипертензия. 2015;21(3):224—30. doi: 10.18705/1607-419X-2015-21-3-224-230][Omran A. R. The Epidemiologic Transition: A Theory of the Epidemiology of Population Change. Milbank Q. 2005;83(4):731—57. doi: 10.1111/j.1468-0009.2005.00398.x][Бойцов С. А. Актуальные направления и новые данные в эпидемиологии и профилактике неинфекционных заболеваний. Терапевтический архив. 2016;88(1):4—10. doi: 10.17116/terarkh20168814-10][Santosa A., Wall S., Fottrell E., Högberg U., Byass P. The development and experience of epidemiological transition theory over four decades: a systematic review. Glob. Health Action. 2014 May 15;7:23574. doi: 10.3402/gha.v7.23574][Firestone R., Cheng S., Pearce N., Douwes J., Merletti F., Pizzi C., et al. Internet-Based Birth-Cohort Studies: Is This the Future for Epidemiology? JMIR Res. Protocols. 2015;4(2):e3873. doi: 10.2196/resprot.3873][Christensen T., Riis A. H., Hatch E. E., Wise L. A., Nielsen M. G., Rothman K. J., et al. Costs and Efficiency of Online and Offline Recruitment Methods: A Web-Based Cohort Study. J. Med. Internet Res. 2017;19(3):e6716. doi: 10.2196/jmir.6716][Nye R. T., Hill D. L., Carroll K. W., Boyden J. Y., Katcoff H., Griffis H., et al. The Design of a Data Management System for a Multicenter Palliative Care Cohort Study. J. Pain Symptom Manage. 2022;64(1):e53—e60. doi: 10.1016/j.jpainsymman.2022.03.007][Griffin A. C., Topaloglu U., Davis S., Chung A. E. From Patient Engagement to Precision Oncology: Leveraging Informatics to Advance Cancer Care. Yearb Med. Inform. 2020;29(1):235—42. doi: 10.1055/s-0040-1701983][Health eHeart Study. Режим доступа: https://www.health-eheartstudy.org/?locale=en (дата обращения 17.05.2022).][Avram R., Tison G. H., Aschbacher K., Kuhar P., Vittinghoff E., Butzner M., et al. Real-world heart rate norms in the Health eHeart study. NPJ Digit. Med. 2019;2:58. doi: 10.1038/s41746-019-0134-9][Heise J. K., Dey R., Emmerich M., Kemmling Y., Sistig S., Krause G., et al. Putting digital epidemiology into practice: PIA-Prospective Monitoring and Management Application. Inform. Med. Unlocked. 2022;30:100931. doi: 10.1016/j.imu.2022.100931][Balleier C., Floßdorf E., Hochbruck M., Kiefer F. Der Kodex “Leitlinien zur Sicherung guter wissenschaftlicher Praxis” der DFG. Mitteilungen der Deutschen Mathematiker-Vereinigung. 2021;29(4):239—42. doi: 10.1515/dmvm-2021-0085][Overhage J. M., Ryan P. B., Reich C. G., Hartzema A. G., Stang P. E. Validation of a common data model for active safety surveillance research. J. Am. Med. Inform. Assoc. 2012;19(1):54—60. doi: 10.1136/amiajnl-2011-000376][Hripcsak G., Duke J. D., Shah N. H., et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud. Health Technol. Inform. 2015;216:574—8.][Informatics Observational Health Data Sciences and. Chapter 1 The OHDSI Community. The Book of OHDSI. Режим доступа: https://ohdsi.github.io/TheBookOfOhdsi/ (дата обращения 15.05.2022).][Kuller L. H. Epidemiologists of the Future: Data Collectors or Scientists? Am. J. Epidemiol. 2019;188(5):890—5. doi: 10.1093/aje/kwy221][Dammann O., Gray P., Gressens P., Wolkenhauer O., Leviton A. Systems Epidemiology: What’s in a Name? Online J. Pub. Health Inform. 2014;6(3):e198. doi: 10.5210/ojphi.v6i3.5571][Wolfson J., Stovitz S. D., Blair S. N., Sui X., Duck-chul L., Shrier I. Decomposing the effects of physical activity and cardiorespiratory fitness on mortality. Glob. Epidemiol. 2019;1:100009. doi: 10.1016/j.gloepi.2019.100009][Lagström H., Stenholm S., Akbaraly T., Pentti J., Vahtera J., Kivimäki M., et al. Diet quality as a predictor of cardiometabolic disease–free life expectancy: the Whitehall II cohort study. Am. J. Clin. Nutr. 2020;111(4):787—94. doi: 10.1093/ajcn/nqz329][Suchard M. A., Schuemie M. J., Krumholz H. M., You S. C., Chen R., Pratt N., et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes. Lancet. 2019;394(10211):1816—26. doi: 10.1016/S0140-6736(19)32317—7][Park J., Choi J., Choi J. Y. Network Analysis in Systems Epidemiology. J. Prev. Med. Public Health. 2021;54(4):259—564. doi: 10.3961/jpmph.21.190][Saracci R. Epidemiology in wonderland: Big Data and precision medicine. Eur. J. Epidemiol. 2018;33(3):245—57. doi: 10.1007/s10654-018-0385-9][Yang A., Troup M., Ho J. W. K. Scalability and Validation of Big Data Bioinformatics Software. Comput. Struct. Biotechnol. J. 2017;15:379—86. doi: 10.1016/j.csbj.2017.07.002][Samet J. M., Woodward A. On Being an Epidemiologist. Am. J. Epidemiol. 2019;188(5):818—24. doi: 10.1093/aje/kwy279][Shah R., Pico A. R., Freedman J. E. Translational Epidemiology: Entering a Brave New World of Team Science. Circ. Res. 2016;119(10):1060—2. doi: 10.1161/CIRCRESAHA.116.309881][Климонтов В. В., Бериков В. Б., Сайк О. В. Искусственный интеллект в диабетологии. Сахарный диабет. 2021;24(2):156—66. doi: 10.14341/DM12665][Oster A. M., France A. M., Mermin J. Molecular Epidemiology and the Transformation of HIV Prevention. JAMA. 2018;319(16):1657—8. doi: 10.1001/jama.2018.1513][Bensyl D. M., King M. E., Greiner A. Applied Epidemiology Training Needs for the Modern Epidemiologist. Am. J. Epidemiol. 2019;188(5):830—5. doi: 10.1093/aje/kwz052][Thacker S. B., Dannenberg A. L., Hamilton D. H. Epidemic Intelligence Service of the Centers for Disease Control and Prevention: 50 Years of Training and Service in Applied Epidemiology. Am. J. Epidemiol. 2001;154(11):985—92. doi: 10.1093/aje/154.11.985][Mukanga D., Namusisi O., Gitta S. N., Pariyo G., Tshimanga M., Weaver A., et al. Field Epidemiology Training Programmes in Africa — Where are the Graduates? Hum. Res. Health. 2010;8(1):18. doi: 10.1186/1478-4491-8-18][Магистерская программа — 32.04.01. «Общественное здравоохранение» профиль «Эпидемиология». Режим доступа: https://www.sechenov.ru/univers/structure/institute/mpf/podrazdeleniya-mpf/kafedry/kafedra-epidemiologii-i-dokazatelnoy-meditsiny-mediko-profilakticheskogo-fakulteta/lorp/ (дата обращения 31.05.2022).][Меньшикова Е. В Университете ИТМО запускается первый в России англоязычный магистерский трек Public Health Sciences. Режим доступа: https://news.itmo.ru/ru/education/students/news/10277/ (дата обращения 31.05.2022).][Gardy J. L., Loman N. J. Towards a genomics-informed, real-time, global pathogen surveillance system. Nat. Rev. Genet. 2018;19(1):9—20. doi: 10.1038/nrg.2017.88][Holmes E. C., Rambaut A., Andersen K. G. Pandemics: spend on surveillance, not prediction. Nature. 2018;558(7709):180—2. doi: 10.1038/d41586-018-05373-w][Metcalf C. J. E., Farrar J., Cutts F. T., Basta N. E., Graham A. L., Lessler J., et al. Use of serological surveys to generate key insights into the changing global landscape of infectious disease. Lancet. 2016;388(10045):728—30. doi: 10.1016/S0140-6736(16)30164—7][Crozier I. Mapping a Filoviral Serologic Footprint in the Democratic Republic of the Congo: Who Goes There? J. Infect. Dis. 2018;217(4):513—5. doi: 10.1093/infdis/jix620][Wikan N., Smith D. R. Zika virus: history of a newly emerging arbovirus. Lancet Infect. Dis. 2016;16(7):e119—e126. doi: 10.1016/S1473-3099(16)30010-X][Katzelnick L. C., Gresh L., Halloran M. E., Mercado J. C., Kuan G., Gordon A., et al. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017;358(6365):929—32. doi: 10.1126/science.aan6836][Cobey S., Hensley S. E. Immune history and influenza virus susceptibility. Curr. Opin. Virol. 2017;22:105—11. doi: 10.1016/j.coviro.2016.12.004][Talking about the Ebola Outbreak with BU Experts on the Disease. Boston University. Режим доступа: https://www.bu.edu/articles/2019/ebola/ (дата обращения 18.05.2022).][Paez-Espino D., Eloe-Fadrosh E. A., Pavlopoulos G. A., Thomas A. D., Huntemann M., Mikhailova N., et al. Uncovering Earth’s virome. Nature. 2016;536(7617):425—30. doi: 10.1038/nature19094][Carroll D., Daszak P., Wolfe N. D., Gao G. F., Morel C. M., Morzaria S., et al. The Global Virome Project. Science. 2018;359(6378):872—4. doi: 10.1126/science.aap7463][Lynch S. V., Pedersen O. The Human Intestinal Microbiome in Health and Disease. Phimister E. G., ed. N. Engl. J. Med. 2016;375(24):2369—79. doi: 10.1056/NEJMra1600266][Dupont H. L., Jiang Z. D., Dupont A. W., Utay N. S. The intestinal microbiome in human health and disease. Trans. Am. Clin. Climatol. Assoc. 2020;131:178—97.][The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women. PubMed. Режим доступа: https://pubmed.ncbi.nlm.nih.gov/31144462/ (дата обращения 15.06.2022).][Ippolito M. M., Denny J. E., Langelier C., Sears C. L., Schmidt N. W. Malaria and the Microbiome: A Systematic Review. Clin. Infect. Dis. 2018;67(12):1831—9. doi: 10.1093/cid/ciy374][Comberiati P., Cicco M. D., Paravati F., Sears C. L., Schmidt N. W. The Role of Gut and Lung Microbiota in Susceptibility to Tuberculosis. Int. J. Environ. Res. Public Health. 2021;18(22):12220. doi: 10.3390/ijerph182212220][Waldman A. J., Balskus E. P. The Human Microbiota, Infectious Disease, and Global Health: Challenges and Opportunities. ACS Infect. Dis. 2018;4(1):14—26. doi: 10.1021/acsinfecdis.7b00232][Libertucci J., Young V. B. The role of the microbiota in infectious diseases. Nat. Microbiol. 2019;4(1):35—45. doi: 10.1038/s41564-018-0278-4][Брико Н. И. Парадигма современной эпидемиологии. Эпидемиология и вакцинопрофилактика. 2013;(6(73)):4—10.][Tacconelli E., Carrara E., Savoldi A., Harbarth S., Mendelson M., Monnet D., et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 2018;18(3):318—27. doi: 10.1016/S1473-3099(17)30753-3][Ma Z., Lee S., Jeong K. C. Mitigating Antibiotic Resistance at the Livestock-Environment Interface: A Review. J. Microbiol. Biotechnol. 2019;29:1683—92. doi.org/10.4014/jmb.1909.09030][Lewnard J. A., Reingold A. L. Emerging Challenges and Opportunities in Infectious Disease Epidemiology. Am. J. Epidemiol. 2019;188(5):873—82. doi: 10.1093/aje/kwy264][Petousis-Harris H., Paynter J., Morgan J., Saxton P., McArdle B., Goodyear-Smith F., et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet (London, England). 2017;390(10102:1603—10. doi: 10.1016/S0140-6736(17)31449-6][Jackson M. L., Chung J. R., Jackson L. A., Phillips C. H., Benoit J., Monto A. S., et al. Influenza Vaccine Effectiveness in the United States during the 2015—2016 Season. N. Engl. J. Med. 2017;377(6):534—43. doi: 10.1056/NEJMoa1700153][Vandenbroucke J. P., Pearce N. Test-Negative Designs: Differences and Commonalities with Other Case–Control Studies with “Other Patient” Controls. Epidemiology. 2019;30(6):838—44. doi: 10.1097/EDE.0000000000001088][Fukushima W., Hirota Y. Basic principles of test-negative design in evaluating influenza vaccine effectiveness. Vaccine. 2017;35(36):4796—800. doi: 10.1016/j.vaccine.2017.07.003][McArthur D. B. Emerging Infectious Diseases. Nurs. Clin. N. Am. 2019;54(2):297. doi: 10.1016/j.cnur.2019.02.006][The Lancet Regional Health-Western Pacific. To end the neglect of neglected tropical diseases. Lancet Reg Health West Pac. 2022;18:100388. doi: 10.1016/j.lanwpc.2022.100388][Neglected tropical diseases. Режим доступа: https://www.who.int/news-room/questions-and-answers/item/neglected-tropical-diseases (дата обращения 18.05.2022).][World Health Organization. Disease burden and mortality estimates. Режим доступа: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates (дата обращения 19.05.2022).][Sixty-sixth World Health Assembly. Режим доступа: https://apps.who.int/gb/ebwha/pdf_files/WHA66-REC1/WHA66_2013_REC1_complete.pdf (дата обращения 19.05.2022).][Bennett J. E., Stevens G. A., Mathers C. D., Bonita R., Rehm J., Kruk M. E., et al. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet. 2018;392(10152):1072—88. doi: 10.1016/S0140-6736(18)31992-5][Global Action Plan for the Prevention and Control of NCDs 2013–2020. Режим доступа: https://www.who.int/publications-detail-redirect/9789241506236 (дата обращения 27.05.2022).][Noncommunicable diseases: Mortality. Режим доступа: https://www.who.int/data/gho/data/themes/topics/sdg-target-3_4-non-communicable-diseases-and-mental-health (дата обращения 27.05.2022).][Goal 3. Department of Economic and Social Affairs. Режим доступа: https://sdgs.un.org/goals/goal3 (дата обращения 27.05.2022).][Об утверждении Стратегии формирования здорового образа жизни населения, профилактики и контроля неинфекционных заболеваний на период до 2025 года от 15 января 2020. Режим доступа: https://docs.cntd.ru/document/564215449 (дата обращения 21.04.2022)][Концевая А. В., Мырзаматова А. О., Муканеева Д. К., Сапунова И. Д., Баланова Ю. А., Худяков М. Б. Экономический ущерб от основных хронических неинфекционных заболеваний в Российской Федерации в 2016 году. Профилактическая медицина. 2019;22(6). doi: 10.17116//profmed20192206118][Камынина Н. Н., Мыльникова Л. А. Факторы риска хронических неинфекционных заболеваний: аналитическое исследование результатов диспансеризации в городе Москве. Проблемы социальной гигиены, здравоохранения и истории медицины. 2020;28(S2):1215—21. doi: 10.32687/0869-866X-2020-28-s2-1215-1221][Баланова Ю. А., Шальнова С. А., Деев А. Д., Имаева А. Э., Концевая А. В., Муромцева Г. А. и др. Ожирение в российской популяции — распространенность и ассоциации с факторами риска хронических неинфекционных заболеваний. Российский кардиологический журнал. 2018;(6):123—30. doi: 10.15829/1560-4071-2018-6-123-130][Жернакова Ю. В., Железнова Е. А., Чазова И. Е., Ощепкова Е. В., Долгушева Ю. А., Яровая Е. Б. Распространенность абдоминального ожирения в субъектах Российской Федерации и его связь с социально-экономическим статусом, результаты эпидемиологического исследования ЭССЕ-РФ. Терапевтический архив. 2018;90(10):14—22. doi: 10.26442/terarkh2018901014-22][Jaacks L. M., Vandevijvere S., Pan A., McGowan C. J., Wallace C., Imamura F., et al. The Obesity Transition: Stages of the global epidemic. Lancet Diabet. Endocrinol. 2019;7(3):231—40. doi:10.1016/S2213-8587(19)30026-9][Ожирение и избыточный вес. Режим доступа: https://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight (дата обращения 23.03.2022).][Endalifer M. L., Diress G. Epidemiology, Predisposing Factors, Biomarkers, and Prevention Mechanism of Obesity: A Systematic Review. J. Obes. 2020;2020:6134362. doi: 10.1155/2020/6134362][Armenta-Guirado B., Martínez-Contreras T., Candia-Plata M. C., Esparza-Romero J., Martínez-Mir R., Haby M. M., et al. Effectiveness of the Diabetes Prevention Program for Obesity Treatment in Real World Clinical Practice in a Middle-Income Country in Latin America. Nutrients. 2019;11(10):2324. doi: 10.3390/nu11102324][Global Burden of Disease 2019 Cancer Collaboration; Kocarnik J. M., Compton K., Dean F. E., Fu W., Gaw B. L., Harvey J. D., Henrikson H. J., Force L. M, et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022;8(3):420—44. doi: 10.1001/jamaoncol.2021.6987][Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer. Режим доступа: https://gco.iarc.fr/today (дата обращения 27.05.2022).][Montagnana M., Lippi G. Cancer diagnostics: current concepts and future perspectives. Ann. Transl. Med. 2017;5(13):268. doi: 10.21037/atm.2017.06.20][Кобякова О. С., Куликов Е. С., Деев И. А., Альмикеева А. А., Пименов И. Д., Старовойтова Е. А. Распространенность факторов риска хронических неинфекционных заболеваний среди медицинских работников. Кардиоваскулярная терапия и профилактика. 2018;17(3):96—104. doi: 10.15829/1728-8800-2018-3-96-104][Epidemiological Changes under the COVID-19 Pandemic: Burden of Diseases and Health Care Outcomes. Frontiers Research Topic. Режим доступа: https://www.frontiersin.org/research-topics/19606/epidemiological-changes-under-the-covid-19-pandemic-burden-of-diseases-and-health-care-outcomes#overview (дата обращения 17.04.2022).][Teoh S. E., Masuda Y., Tan D. J. H., Liu N., Morrison L. J, Ong M. E. H., et al. Impact of the COVID-19 pandemic on the epidemiology of out-of-hospital cardiac arrest: a systematic review and meta-analysis. Ann. Intensive Care. 2021;11(1):169. doi: 10.1186/s13613-021-00957-8][Aburto J. M., Schöley J., Kashnitsky I., Zhang L., Rahal C., Missov T. I., et al. Quantifying impacts of the COVID-19 pandemic through life-expectancy losses: a population-level study of 29 countries. Int. J. Epidemiol. 2022;51(1):63—74. doi: 10.1093/ije/dyab207][Tanislav C., Kostev K. Investigation of the prevalence of non-COVID-19 infectious diseases during the COVID-19 pandemic. Public Health. 2022;203:53—7. doi: 10.1016/j.puhe.2021.12.003][Chang A. Y., Cullen M. R., Harrington R. A., Barry M. The impact of novel coronavirus COVID‐19 on noncommunicable disease patients and health systems: a review. J. Intern. Med. 2021 Apr;289(4):450—62. Epub 2020 Oct 27. doi: 10.1111/joim.13184][McGurnaghan S. J., Weir A., Bishop J., et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabet. Endocrinol. 2021;9(2):82—93. doi: 10.1016/S2213-8587(20)30405-8][Strambo D., De Marchis G. M., Bonati L. H., Arnold M., et al. Ischemic stroke in COVID-19 patients: Mechanisms, treatment, and outcomes in a consecutive Swiss Stroke Registry analysis. Eur. J. Neurol. 2022;29(3):732—43. doi: 10.1111/ene.15199][Wu Z., McGoogan J. M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239—42. doi: 10.1001/jama.2020.2648][Gasmi A., Peana M., Pivina L., et al. Interrelations between COVID-19 and other disorders. Clin. Immunol. 2021;224:108651. doi: 10.1016/j.clim.2020.108651][Pranata R., Henrina J., Raffaello W. M., Lawrensia S., Huang I. Diabetes and COVID-19: The past, the present, and the future. Metabolism. 2021;121:154814. doi: 10.1016/j.metabol.2021.154814][Cariou B., Hadjadj S., Wargny M., Pichelin M., Al-Salameh A., Allix I., et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63(8):1500—15. doi: 10.1007/s00125-020-05180-x][World Health Organization — COVID-19 significantly impacts health services for noncommunicable diseases. Режим доступа: https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases (дата обращения 17.04.2022).][COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700—12. doi: 10.1016/S0140-6736(21)02143-7][Dubé J. P., Smith M. M., Sherry S. B., Hewitt P. L., Stewart S. H. Suicide behaviors during the COVID-19 pandemic: A meta-analysis of 54 studies. Psychiatry Res. 2021;301:113998. doi: 10.1016/j.psychres.2021.113998][Soleimanpour S., Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev. Vaccines. 2021;20(1):23—44. doi: 10.1080/14760584.2021.1875824][Pietzner M., Stewart I. D., Raffler J., Khaw K.-T., Michelotti G. A., Kastenmüller G., et al. Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat. Med. 2021;27(3):471—9. doi: 10.1038/s41591-021-01266-0][Young V. B. The role of the microbiome in human health and disease: an introduction for clinicians. BMJ. 2017;356:j831. doi: 10.1136/bmj.j831]